Chicago, IL 4/5/12 (StreetBeat) -- Research firm Taglich Brothers has initiated coverage on ALR Technologies, Inc. (OTCBB: ALRT); issuing a “Speculative Buy” rating and a $0.50, 12-month price target on the healthcare technology company and developer of the Health-e-Connect (HeC) system. HeC is an FDA-cleared Internet-based system from chronic disease management. A scalable technology for a wide array of chronic diseases, HeC is initially being marketed by ALR Technologies as a solution for better diabetes management, a multi-billion dollar industry.Shares of ALRT closed trading on Wednesday and $0.09 and are trading up 10% at $0.099 in early trading this morning.
According to the Taglich report,
“Internet-Based Glucose Monitoring Systems (IBGMS) are poised to assume a key, lucrative role in the management of millions of diagnosed US diabetics.
One such system, ALR’s Health-e-Connect (HeC), offers a low-cost, universally compatible means of facilitating effective disease management through the exchange of patient self-monitored diagnostic data and clinician feedback over the Internet.”
Taking a succinct look at the industry, the report analyzes market trends and future growth as well as drawing comparisons of ALRT to its industry peers. Other components of the analysis include target markets for ALRT (health insurers, pharmaceutical manufacturers and pharmacies), discussions of benefits of adopting technologies like ALRT’s by Medicare, the proven benefits of glucose monitoring technologies, competitors and much more.
The investment community is encouraged to download and read the complete Taglich Brothers Analyst Report on ALR Technologies.
Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.
StreetBeat Disclaimer
No comments:
Post a Comment